DRU-023: Implementation and Use of Effective Prescription Drug Monitoring Programs
Implementation and Use of Effective Prescription Drug Monitoring Programs: The Wisconsin Medical Society:
- Recommends that Prescription Drug Monitoring Programs (PDMP) be user-friendly and designed such that data is available immediately after a prescription is filed, and is available immediately to clinicians or their designees with prescribing authority when they query the database and are considering prescribing a controlled substance.
- Recommends that individual PDMP databases be designed with the best available connectivity to electronic medical records, and with connectivity to other PDMP databases so that clinicians or their designees with prescribing authority can have access to PDMP controlled substances dispensing data across state boundaries or between prescribing agencies.
- Encourages clinicians or their designees with prescribing authority to use PDMP databases before prescribing prescription drugs, and to actively discuss the importance of medication safety with their patients.
- Considers PDMP data to be protected health information, and thus protected from release outside the health care system unless there is a HIPAA exception or specific authorization from the individual patient to release personal health information.
- Supports medical school and postgraduate training that incorporates curriculum topics focusing on pain medicine, addiction medicine and how best to utilize PDMP platforms for safe prescribing practices. (HOD, 0416)